Drug reference
metformin-repaglinide
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Endocrine (Insulin secretagogues)
Mechanism of action
Increases insulin secretion by blocking ATP potassium channels on beta islet cells, which facilitates calcium entry through calcium channels; increased intracellular calcium stimulates insulin release from pancreatic beta cells
Common side effects
- Vomiting
- Headache
- Nausea
- Symptomatic hypoglycemia
- Diarrhea
Known interactions (1)
- gemfibrozil + metformin-repaglinide Contraindicated
Related conditions
Frequently asked questions
What drug class is metformin-repaglinide?
metformin-repaglinide belongs to: Endocrine.
How does metformin-repaglinide work?
Increases insulin secretion by blocking ATP potassium channels on beta islet cells, which facilitates calcium entry through calcium channels; increased intracellular calcium stimulates insulin release from pancreatic beta cells
What are the common side effects of metformin-repaglinide?
Vomiting, Headache, Nausea, Symptomatic hypoglycemia, Diarrhea
Which drugs interact with metformin-repaglinide?
gemfibrozil
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.